CMSC: Consortium of Multiple Sclerosis Centers
Conference Coverage
Inebilizumab beneficial across genotypes in NMOSD
"These data illustrate how mechanistic precision in treatment design can help patients gain benefit from their regimen regardless of the genetic...
Conference Coverage
Stem cell transplants for MS are a ‘reasonable option,’ but questions persist
Costly procedures help some patients but where to draw the line is unclear.
Conference Coverage
MS and COVID-19: Conflicting signs on risk but some trends are clearer
Patients on certain DMTs seem to fare worse and careful timing of vaccination is advisable.
Conference Coverage
Non-White subjects are sparse in DMT trials for MS
Black people only made up 1.9% of participants in studies reporting full racial data over 25 years.
Conference Coverage
B-cell repletion is common with MS drug, but no symptom worsening
While “surprising,” these findings do not prove that B-cell repletion does not put someone at risk.
Conference Coverage
Brief, automated cognitive test may offer key advantages in MS
The automated NIH Toolbox Cognition Battery may be used as an alternative to other gold-standard measures which may cover limited domains or...
Conference Coverage
Specialty pharmacists may speed time to MS treatment
Because there currently is no established DMT selection algorithm, specialty pharmacists can assist in medication education and management.
Conference Coverage
Cannabis use common for MS-related spasticity
The new data reflect the latest patterns of use amid sweeping changes in recreational and medical marijuana laws.
Conference Coverage
New consensus guideline on clinical MRI use in MS
The updated protocol is beneficial in providing “simple, reasonable guidelines that can be easily acquired at almost any imaging location in the U...
Conference Coverage
Multiple DMTs linked to alopecia, especially in women
Several medications weren’t previously implicated in hair loss, researchers report.
Conference Coverage
Certain DMTs in MS linked to more psoriasis
Few cases overall were reported, but researchers still urge caution in drug selection.
Conference Coverage
Two diets linked to improved cognition, fatigue in MS
These results are among the first to show diet-related favorable reductions in cognitive dysfunction.
Conference Coverage
MS and COVID: Docs switched DMTs but maybe didn’t need to
Switching was rampant early on, a survey finds, but a new study suggests specific drugs don’t boost risk.
Conference Coverage
Good data is lacking on best first-line MS drug strategies
But new studies will offer guidance on escalation versus early-intensive approaches.
Conference Coverage
Pain in MS: Focus on flexibility, multiple strategies, and nondrug treatments
Specialist urges colleagues to think outside the pharmacy and understand syndromes.